Canadian Pharmaceuticals & Biotech High Growth Potential Companies

Rakovina Therapeutics

Market Cap: CA$11.8m

A biopharmaceutical research company, engages in the research and development of cancer treatments based on novel series of small-molecule DNA-damage response targets.

Sernova Biotherapeutics

Market Cap: CA$62.4m

Operates as a clinical-stage biotechnology company in Canada.

Medexus Pharmaceuticals

Market Cap: CA$90.6m

Operates as a pharmaceutical company in Canada and the United States.

Theratechnologies

Market Cap: CA$206.5m

A biopharmaceutical company, focuses on the commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe.

Aurora Cannabis

Market Cap: CA$371.5m

Engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.

High Tide

Market Cap: CA$345.1m

Engages in the cannabis retail business in Canada.

Curaleaf Holdings

Market Cap: CA$2.7b

Produces and distributes cannabis products in the United States and internationally.

Cronos Group

Market Cap: CA$1.3b

A cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally.

Green Thumb Industries

Market Cap: CA$2.4b

Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.

Knight Therapeutics

Market Cap: CA$636.8m

Focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products in Canada and Latin America.

Rubicon Organics

Market Cap: CA$36.3m

Engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally.

Decibel Cannabis

Market Cap: CA$77.9m

An integrated cannabis company, engages in the cannabis cultivation in Canada.